Morocco Receives First Shipment of Single-Dose Johnson & Johnson Vaccine

This Janssen vaccine, the statement from the ministry indicates, is a viral vector vaccine, with the particularity of being able to be inoculated in a single dose, unlike the other vaccines in circulation which require two doses.

300,000 doses will therefore be delivered to the kingdom as part of the international Covax program led under the auspices of the WHO, which aims to provide Covid-19 vaccines equitably and quickly to nearly 200 countries.

Regarding efficacy, Johnson & Johnson has stated that its vaccine was 66% effective overall: the results of phase 3 clinical trials show an efficacy between 57% and 72% depending on the territories for preventing moderate and severe forms of the virus, 28 days after vaccination.

The American laboratory especially guarantees a reliable 85% protection against severe forms and "complete protection against Covid-19-relate